title: Massive rhabdomyolysis and life threatening hyperkalaemia in a patient with the combination of cerivastatin and gemfibrozil.
authors.affiliation: Department of Internal Medicine, Horacio Oduber Ziekenhuis, Aruba, The Netherlands.
authors.forename: F
authors.initials: F
authors.lastname: Hendriks
authors.forename: J P
authors.initials: JP
authors.lastname: Kooman
authors.forename: F M
authors.initials: FM
authors.lastname: van der Sande
mesh_terms: D000368:Aged; D002637:Chest Pain / Q000139:chemically induced / Q000175:diagnosis; D004338:Drug Combinations; D004562:Electrocardiography; D005260:Female; D015248:Gemfibrozil / Q000009:adverse effects*; D006801:Humans; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors / Q000627:therapeutic use*; D006947:Hyperkalemia / Q000139:chemically induced* / Q000628:therapy; D000960:Hypolipidemic Agents / Q000009:adverse effects*; D018482:Muscle, Skeletal / Q000187:drug effects; D010146:Pain / Q000139:chemically induced; D011725:Pyridines / Q000009:adverse effects*; D006435:Renal Dialysis; D012206:Rhabdomyolysis / Q000139:chemically induced* / Q000628:therapy
chemical_list: D004338:Drug Combinations; D019161:Hydroxymethylglutaryl-CoA Reductase Inhibitors; D000960:Hypolipidemic Agents; D011725:Pyridines; C086276:cerivastatin; D015248:Gemfibrozil